For years, researchers studying chronic traumatic encephalopathy, or CTE, believ...
“Approaches targeted to prevent this post-therapy cancer cell repopulation shoul...
Credit: Baylor University Journal Frontiers in Marine Science DOI 10.3389/fmars....
Mario Romero-Ortega was selected through a nationwide search to head the Univers...
A layperson might think of “frail” as simply a synonym for “weak” or “fragile.” ...
The Bachman’s warbler, a songbird that was last seen in North America nearly 40 ...
Despite being best recognized for its biosimilars business, Coherus has been try...
The FDA has blocked the approval of Intercept’s NASH therapy, pushing the compan...
IRBM has extended its collaboration with MSD to develop peptide therapeutics, fo...
Sarepta will now need to complete a confirmatory trial to prove the therapy impr...
NephroDI Therapeutics has signed a deal with the McQuade Center for Strategic Re...
Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in Ind...
The regulatory framework governing medicine development is in flux. CDMOs face g...
Erasca has obtained orphan drug designation (ODD) from the US FDA for ERAS-801 t...
Talaris Therapeutics has entered into a definitive agreement to merge with late-...
Kymera Therapeutics has announced that the FDA has granted KT-253 orphan drug de...
